|
24
|
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
PAR-25-371 · National Institutes of Health · basic research
|
biomedical clinical
public health
social services
|
— |
2025-01-13 |
2026-11-18 |
13 |
|
22
|
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
PAR-25-095 · National Institutes of Health · basic research
|
biomedical clinical
ai data science
public health
|
$350,000 |
2024-11-18 |
2026-11-06 |
1 |
|
12
|
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
PAR-25-255 · National Institutes of Health · basic research
|
biomedical clinical
ai data science
public health
|
— |
2024-11-15 |
2026-11-05 |
0 |
|
12
|
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
PAR-25-370 · National Institutes of Health · basic research
|
biomedical clinical
public health
arts humanities culture
|
$50,000 |
2025-01-13 |
2026-11-16 |
11 |
|
12
|
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
PAR-25-369 · National Institutes of Health · basic research
|
biomedical clinical
public health
education workforce
|
— |
2025-01-13 |
2026-11-18 |
13 |
|
12
|
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)
PAR-25-256 · National Institutes of Health · basic research
|
biomedical clinical
ai data science
public health
|
— |
2024-11-15 |
2027-01-07 |
63 |
|
8
|
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)
PAR-25-069 · National Institutes of Health · basic research
|
biomedical clinical
public health
ai data science
|
— |
2024-11-18 |
2027-01-07 |
63 |
|
8
|
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)
PAR-25-070 · National Institutes of Health · basic research
|
biomedical clinical
public health
|
— |
2024-11-18 |
2027-01-07 |
63 |
|
5
|
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
PAR-25-081 · National Institutes of Health · basic research
|
biomedical clinical
public health
computing communications
|
$499,999 |
2024-11-12 |
2027-01-07 |
63 |